Remove 2025 Remove Patent Application Remove Settlement
article thumbnail

SpicyIP Weekly Review (January 13 – January 19)

SpicyIP

Case Summaries Gilead Sciences Inc vs Union Of India on 19 December, 2024 (Madras High Court) Image from here The writ petition pertains to a patent application filed by the petitioner, which was contested by the 4 th respondent through a post-grant opposition. Read this post by Aditi Agrawal discussing these issues!

article thumbnail

SpicyIP Weekly Review (February 17 – February 23)

SpicyIP

Comments Invited on AI Governance and Guidelines Development Report (February 27) The office of CGPDTM has invited comments on the Draft Guidelines for Processing Patent Applications of Ayush Systems and Related Inventions for providing clarity on the filing and processing of patent applications of Ayush Systems and related inventions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SpicyIP Weekly Review (February 17 – February 23)

SpicyIP

Comments Invited on AI Governance and Guidelines Development Report (February 27) The office of CGPDTM has invited comments on the Draft Guidelines for Processing Patent Applications of Ayush Systems and Related Inventions for providing clarity on the filing and processing of patent applications of Ayush Systems and related inventions.

article thumbnail

SpicyIP Weekly Review (March 24 – March 30)

SpicyIP

CRI Guidelines 2025 is out for Public Consultations! The Draft Guidelines for Examination of Computer-Related Inventions (CRI), 2025, has been published for public consultation. Interested stakeholders can provide their comments on the guidelines by April 15, 2025. Read the post for more details. Part I] Safe Harbor in Jeopardy?

article thumbnail

Biosimilar Maker Leverages IPR to Avoid Patent Dance and Obtain Early Market Entry

Bio Law Blog

On May 28, Alexion and Amgen entered into a confidential settlement agreement to terminate the IPRs. Pursuant to the terms of the settlement agreement, effective March 1, 2025 (or earlier in certain circumstances), Alexion grants to Amgen a nonexclusive, royalty-free license under U.S. an eculizumab product.

article thumbnail

SpicyIP Weekly Review (July 1-July 7)

SpicyIP

Here is our recap of last week’s top IP developments including summary of the posts on the DHC’s direction to frame a code of conduct for Patent and Trademark Agents, MHC’s decision on prior arts, and the settlement between Dabur and Dhruv Rathee of their trademark and copyright dispute. Anything we are missing out on?

article thumbnail

SpicyIP Weekly Review (February 3 – February 9)

SpicyIP

Lodha TM battle Following disagreements over how a family settlement agreement is to be interpreted, the Lodha brothers are tangling over the Lodha trademark. Union Budget 2025-26: Whats in it for Innovation, Tech, Trade and Health? The FM Nirmala Sitharaman on February 1 presented the Union Budget 2025-26. amongst others.